Lucid Diagnostics Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Lucid Diagnostics Inc. (LUCD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 46.92 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 54.77M shares, a 17.21% decline year-over-year.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 66.15M shares, a 43.12% increase year-over-year.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 46.22M shares, a 124.13% increase year-over-year.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 20.62M shares, a 302.34% increase year-over-year.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 66.35M shares, a 6.75% increase from fiscal 2024.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 62.15M shares, a 187.92% increase from fiscal 2023.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 21.59M shares, a 363.55% increase from fiscal 2022.
- Lucid Diagnostics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.66M shares, a 38.60% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 46.92M shares 10-Q · filed 2026-08-12 | |||||
| 2026-03-31 | 54.77M shares 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | 66.35M shares 10-K · filed 2026-03-25 | |||||
| 2025-09-30 | 66.00M shares 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | 66.02M shares 10-Q · filed 2026-08-12 | |||||
| 2025-03-31 | 66.15M shares 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | 62.15M shares 10-K · filed 2026-03-25 | |||||
| 2024-09-30 | 64.24M shares 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | 64.32M shares 10-Q · filed 2025-08-12 | |||||
| 2024-03-31 | 46.22M shares 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | 21.59M shares 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | 20.43M shares 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | 20.52M shares 10-Q · filed 2024-08-12 | |||||
| 2023-03-31 | 20.62M shares 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | 4.66M shares 10-K · filed 2024-03-25 | |||||
| 2022-09-30 | 4.72M shares 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | 4.72M shares 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | 5.13M shares 10-Q · filed 2023-05-15 | 5.55M shares 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | 3.36M shares 10-K · filed 2023-03-14 | |||||
| 2021-09-30 | 3.21M shares 10-Q · filed 2022-11-14 | 3.21M shares 10-Q · filed 2021-11-23 | ||||
| 2021-06-30 | 2.95M shares 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | 2.61M shares 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | 1.40M shares 10-K · filed 2022-04-06 | |||||
| 2020-09-30 | 1.40M shares 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |